SCHEMBL6009258

SCHEMBL6009258

O=C(Cc1ccc(Cl)c(Cl)c1)NC(CCN1CCC(Cc2ccccc2)CC1)c1ccccc1

nearest known ligand 0.54

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 2/20 0.54
CCR5 P51681 3/20 0.54
SLC6A2 P23975 4/20 0.50
SLC6A3 Q01959 4/20 0.50
HTT P42858 1/20 0.50
NPFFR1 Q9GZQ6 1/20 0.49
NPFFR2 Q9Y5X5 1/20 0.49
SLC6A4 P31645 1/20 0.47
GRIN2D O15399 1/20 0.47
GRIN3B O60391 1/20 0.47
ADRA1D P25100 1/20 0.47
ADRA1A P35348 1/20 0.47
ADRA1B P35368 1/20 0.47
GRIN1 Q05586 1/20 0.47
GRIN2A Q12879 1/20 0.47
GRIN2B Q13224 1/20 0.47
GRIN2C Q14957 1/20 0.47
GRIN3A Q8TCU5 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6008659 0.86 KCNH2 (0.53) SIGMAR1CCR5HTT
SCHEMBL6008192 0.82 SLC6A2 (0.47) SIGMAR1CCR5SLC6A2SLC6A3SLC6A4
SCHEMBL6008834 0.81 SIGMAR1 (0.56) SIGMAR1HTTNPFFR1NPFFR2GRIN2D
SCHEMBL6974499 0.80 SIGMAR1 (0.54) SIGMAR1CCR5HTT
SCHEMBL6974500 0.80 SIGMAR1 (0.54) SIGMAR1CCR5HTT
SCHEMBL6007211 0.80 SLC6A2 (0.60) CCR5SLC6A2SLC6A3GRIN2DGRIN3B
SCHEMBL24360664 0.79 SIGMAR1 (0.53) SIGMAR1CCR5HTT
SCHEMBL6008029 0.79 CCR3 (0.60) CCR5SLC6A2SLC6A3SLC6A4GRIN2D
SCHEMBL13929329 0.78 SIGMAR1 (0.72) SIGMAR1CCR5HTT
Hydrochloric Acid SCHEMBL8904937 0.78 MCHR1 (0.56) SLC6A2SLC6A3SLC6A4GRIN2DGRIN3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7078537-B2 Phenylalkyl diamine and amide analogs SK CORPORATION (KR) 2006-07-18 US claimed
US-20030105079-A1 Novel phenylalkyl diamine and amide analogs SK BIOPHARMACEUTICALS CO., LTD. (KR) 2003-06-05 US claimed
US-7078537-B2 Phenylalkyl diamine and amide analogs SK CORPORATION (KR) 2006-07-18 US disclosed
US-20030105079-A1 Novel phenylalkyl diamine and amide analogs SK BIOPHARMACEUTICALS CO., LTD. (KR) 2003-06-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030105079-A1 Novel phenylalkyl diamine and amide analogs SIGMAR1, TAAR1, OPRL1 SIGMAR1 1/4885CCR5 796/4885SLC6A2 20/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.